Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
| Page standards status: Informative |
<Composition xmlns="http://hl7.org/fhir">
<id value="568069"/>
<meta>
<versionId value="2"/>
<lastUpdated value="2026-05-31T00:21:11.090Z"/>
<profile
value="http://hl7.org/fhir/uv/ebm/StructureDefinition/m11-report-section-12"/>
</meta>
<language value="en"/>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: Composition 568069</b></p><a name="568069"> </a><a name="hc568069"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">version: 2; Last updated: 2026-05-31 00:21:11+0000</p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-m11-report-section-12.html">M11ReportSection12</a></p></div><p><b>ArtifactPublicationStatus</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/cited-artifact-status-type active}">Active</span></p><p><b>url</b>: <a href="https://fevir.net/resources/Composition/568069">https://fevir.net/resources/Composition/568069</a></p><p><b>identifier</b>: FEvIR Object Identifier/568069</p><p><b>status</b>: Final</p><p><b>type</b>: <span title="Codes:{http://loinc.org 35528-9}">CeSHarP Report</span></p><p><b>category</b>: <span title="Codes:{http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl C218666}">section12-supporting-details</span></p><p><b>date</b>: 2026-05-31 00:21:11+0000</p><p><b>author</b>: Brian S. Alper, MD, MSPH</p><p><b>title</b>: M11 Report Section 12 (Supporting Details) for A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus - M11 Example</p><p><b>custodian</b>: <a href="Organization-118079.html">Computable Publishing LLC</a></p><blockquote><p><b>relatesTo</b></p><p><b>type</b>: Derived From</p><p><b>target</b>: <a href="ResearchStudy-267245.html">A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus - M11 Example</a></p></blockquote><blockquote><p><b>relatesTo</b></p><p><b>type</b>: Cite As</p><p><b>target</b>: </p><div><p>M11 Report Section 12 (Supporting Details) for A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus - M11 Example [Database Entry: FHIR Composition Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 568069. Revised 2026-05-31. Available at: https://fevir.net/resources/Composition/568069. Computable resource at: https://fevir.net/resources/Composition/568069#json.</p>
</div></blockquote></div>
</text>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status">
<valueCodeableConcept>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/cited-artifact-status-type"/>
<code value="active"/>
<display value="Active"/>
</coding>
</valueCodeableConcept>
</extension>
<url value="https://fevir.net/resources/Composition/568069"/>
<identifier>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
<code value="ACSN"/>
<display value="Accession ID"/>
</coding>
<text value="FEvIR Object Identifier"/>
</type>
<system value="https://fevir.net/FOI"/>
<value value="568069"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<status value="final"/>
<type>
<coding>
<system value="http://loinc.org"/>
<code value="35528-9"/>
<display value="Clinical trial protocol Clinical trial protocol"/>
</coding>
<text value="CeSHarP Report"/>
</type>
<category>
<coding>
<system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl"/>
<code value="C218666"/>
<display
value="ICH M11 Protocol Section 12 APPENDIX: SUPPORTING DETAILS"/>
</coding>
<text value="section12-supporting-details"/>
</category>
<subject>🔗
<reference value="ResearchStudy/267245"/>
<type value="ResearchStudy"/>
<display
value="A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus - M11 Example"/>
</subject>
<date value="2026-05-31T00:21:11.090Z"/>
<author>
<display value="Brian S. Alper, MD, MSPH"/>
</author>
<title
value="M11 Report Section 12 (Supporting Details) for A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus - M11 Example"/>
<custodian>🔗
<reference value="Organization/118079"/>
<type value="Organization"/>
<display value="Computable Publishing LLC"/>
</custodian>
<relatesTo>
<type value="derived-from"/>
<targetReference>🔗
<reference value="ResearchStudy/267245"/>
<type value="ResearchStudy"/>
<display
value="A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus - M11 Example"/>
</targetReference>
</relatesTo>
<relatesTo>
<type value="cite-as"/>
<targetMarkdown
value="M11 Report Section 12 (Supporting Details) for A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus - M11 Example [Database Entry: FHIR Composition Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 568069. Revised 2026-05-31. Available at: https://fevir.net/resources/Composition/568069. Computable resource at: https://fevir.net/resources/Composition/568069#json."/>
</relatesTo>
<section>
<title value="Appendix: Supporting Details"/>
<code>
<coding>
<system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl"/>
<code value="C218666"/>
<display
value="ICH M11 Protocol Section 12 APPENDIX: SUPPORTING DETAILS"/>
</coding>
<text value="section12-supporting-details"/>
</code>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml">[No text is intended here (heading only).]</div>
</text>
<section>
<title value="Clinical Laboratory Tests"/>
<code>
<coding>
<system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl"/>
<code value="C218667"/>
<display
value="ICH M11 Protocol Section 12.1 Clinical Laboratory Tests"/>
</coding>
<text value="section12.1-clinical-laboratory-tests"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>7 pages of images replaced with this statement.</p></div>
</text>
</section>
<section>
<title value="Country/Region-Specific Differences"/>
<code>
<coding>
<system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl"/>
<code value="C218668"/>
<display
value="ICH M11 Protocol Section 12.2 Country/Region-Specific Differences"/>
</coding>
<text value="section12.2-country-specific-differences"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>Not applicable.</p></div>
</text>
</section>
<section>
<title value="Prior Protocol Amendment(s)"/>
<code>
<coding>
<system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl"/>
<code value="C218669"/>
<display
value="ICH M11 Protocol Section 12.3 Prior Protocol Amendment(s)"/>
</coding>
<text value="section12.3-prior-protocol-amendments"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>Not applicable. This is the first protocol amendment.</p></div>
</text>
</section>
</section>
</Composition>